6-Methylmercapto-9-(b-D-ribofuranosyl)purine

CAS : 342-69-8

Ref. 3D-NM06304

Informations sur le produit

• Nom: 6-Methylmercapto-9-(b-D-ribofuranosyl)purine
• Synonymes: 6-(Methylmercapto)-9-(β-<span class="text-smallcaps">D</span>-ribofuranosyl)purine, 6-(Methylmercapto)purine ribonucleoside, 6-(Methylthio)-9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-9H-purine, 6-(Methylthio)-9-β-<span class="text-smallcaps">D</span>-ribofuranosylpurine, 6-(Methylthio)purine ribonucleoside, 6-Methylmercapto-9-(β-D-ribofuranosyl)purine, 6-Methylthioinosine, 6-Methylthiopurine riboside, 6-Mmpr, 6-S-Methyl-6-thioinosine, 9H-Purine, 6-(methylthio)-9-β-<span class="text-smallcaps">D</span>-ribofuranosyl-, Inosine, 6-S-methyl-6-thio-, Methylthioinosine, NSC 40774, NSC 49555, Sq 21977, β-<span class="text-smallcaps">D</span>-Ribosyl-6-methylthiopurine, 6-Methylmercaptopurine riboside, 9H-Purine, 6-(methylthio)-9-β-D-ribofuranosyl-

Description

6-Methylmercapto-9-(b-D-ribofuranosyl)purine (6MMPR) is a nucleotide analog that is synthesized through the process of ribosylation. It has been shown to be reactive and inflammatory in the colon, which may be due to its role as an enzyme inhibitor. 6MMPR inhibits target enzymes such as 2-methylthio-6-chloropurine riboside, which are involved in DNA synthesis and repair. This drug also has anti-inflammatory properties, which may be due to its ability to inhibit the production of inflammatory cytokines by activated immune cells. 6MMPR is used for the treatment of bowel diseases such as Crohn's disease and ulcerative colitis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 298.32 g/mol
• Formule: C₁₁H₁₄N₄O₄S
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder